Glen Harbor Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Glen Harbor Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$7.76M	Buy	153,120 +47,584	+45%	+$2.24M	0.16%	127
2019 Q2	$4.79M	Buy	105,536 +79,392	+304%	+$3.7M	0.1%	196
2019 Q1	$1.25M	Buy	26,144 +10,816	+71%	+$539K	0.03%	418
2018 Q4	$797K	Sell	15,328 -2,144	-12%	-$115K	0.02%	480
2018 Q3	$1.08M	Sell	17,472 -272	-2%	-$16.1K	0.02%	454
2018 Q2	$982K	Sell	17,744 -3,408	-16%	-$184K	0.02%	441
2018 Q1	$1.34M	Buy	21,152 +3,408	+19%	+$219K	0.03%	356
2017 Q4	$1.09M	Buy	17,744 +8,272	+87%	+$517K	0.02%	412
2017 Q3	$604K	Buy	+9,472	New	+$553K	0.01%	539
2017 Q1	–	Sell	-10,176	Closed	-$595K	–	1272
2016 Q4	$595K	Buy	+10,176	New	+$556K	0.02%	460

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glen Harbor Capital Management's BMY Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Bristol-Myers Squibb (BMY) stake by 45% in Q3 2019, buying an estimated $2.24M and bringing the position to 153,120 shares worth $7.76M. The position accounts for 0.16% of the portfolio, ranked #127.

Glen Harbor Capital Management first reported a position in BMY in Q4 2016 and has held it in 10 quarters since. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Glen Harbor Capital Management held 153,120 shares of Bristol-Myers Squibb worth $7.76M as of Q3 2019.
Glen Harbor Capital Management bought 47,584 Bristol-Myers Squibb shares in Q3 2019, an estimated $2.24M.
Bristol-Myers Squibb made up 0.16% of Glen Harbor Capital Management's portfolio in Q3 2019, its #127 holding.
Glen Harbor Capital Management first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 10 quarters since.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.